NAD+ is an essential cellular coenzyme involved in redox chemistry and energy metabolism. As a substrate for sirtuins, PARPs and CD38, it is researched in mitochondrial regulation, DNA-damage signalling, stress responses and metabolic communication.
Current work examines NAD+ availability and NAD-dependent pathways as mechanistic and translational research questions, not established clinical benefits.
Explore NAD+ researchResearch context only; not a therapeutic claim.GHK-Cu is a copper-binding tripeptide studied in gene-expression, extracellular-matrix, collagen- and elastin-related pathways, cellular migration, copper homeostasis and oxidative-stress responses.
Research also examines skin and tissue-repair mechanisms. Evidence remains primarily laboratory, preclinical or cosmetic and does not establish a therapeutic benefit.
Explore GHK-Cu researchResearch context only; not a therapeutic claim.Browse compounds studied in growth-hormone-releasing hormone, ghrelin-receptor, pituitary-signalling, and related endocrine research models. Individual listings provide product-specific context, handling information, and available documentation.
For lawful laboratory, analytical, and in-vitro research only. No clinical outcome or therapeutic use is implied.
Five key research areas Growth-hormone pulses — studied for two complementary upstream routes to growth-hormone release. IGF-1 pathways — investigates downstream signalling involved in growth, metabolism and tissue turnover....
Buy now
Five key research areas Growth-hormone release — activates GHRH receptors and increases growth-hormone/IGF-1 signalling. Visceral fat — regulated trials examined abdominal fat surrounding internal organs in specific populati...
Buy now
Five key research areas Growth-hormone release — activates the ghrelin receptor and is studied for pituitary growth-hormone secretion. Appetite — ghrelin-receptor activity is closely connected with hunger and feeding signals...
Buy now
Five key research areas Growth-hormone signalling — designed to activate the GHRH receptor, which signals the pituitary to release growth hormone. IGF-1 pathways — studied for downstream signalling involved in cell growth, t...
Buy now
Five key research areas Complementary signalling — CJC targets the GHRH receptor while GHRP-6 targets the ghrelin receptor. Hormone pulses — studied for whether the two pathways alter the strength and timing of growth-hormon...
Buy now
Five key research areas Growth-hormone release — activates GHRH receptors and increases growth-hormone/IGF-1 signalling. Visceral fat — regulated trials examined abdominal fat surrounding internal organs in specific populati...
Buy now